Triple Therapy in Asthma - Your Questions Answered
Asthma is a chronic respiratory condition characterised by airway inflammation, bronchoconstriction, and airway hyperresponsiveness. While most patients achieve control with standard therapies such as inhaled corticosteroids (ICS) combined with long‑acting beta‑agonists (LABA), a subset of individuals with moderate to severe disease continue to experience symptoms and exacerbations despite appropriate treatment. For these patients, guideline‑informed step‑up therapy may include adding a long‑acting muscarinic antagonist (LAMA) to their regimen—creating what is known as triple therapy (ICS + LABA + LAMA). Triple therapy aims to provide broader bronchodilation and enhanced anti‑inflammatory effects, targeting different pathways within the airway.
.jpg)
Learning Outcomes
What you'll learn
- Describe the components and mechanisms of triple therapy in asthma.
- Identify appropriate clinical indications for triple therapy.
- Assess patient suitability for step‑up to triple therapy.
- Implement triple therapy with attention to inhaler technique and adherence.
- Monitor treatment efficacy and adjust therapy based on clinical response.
- Counsel patients effectively about expected benefits, risks, and correct inhaler use.
Stay updated with our


Learning Outcomes
What you'll learn
- Describe the components and mechanisms of triple therapy in asthma.
- Identify appropriate clinical indications for triple therapy.
- Assess patient suitability for step‑up to triple therapy.
- Implement triple therapy with attention to inhaler technique and adherence.
- Monitor treatment efficacy and adjust therapy based on clinical response.
- Counsel patients effectively about expected benefits, risks, and correct inhaler use.
Stay updated with our


Training Overview
- What is Triple Therapy in Asthma?
- When to Consider Triple Therapy
- Evidence and Outcomes with Triple Therapy
- Implementing Triple Therapy in Practice
- Monitoring and Adjusting Triple Therapy
- Patient Education and Shared Decision‑Making
- Summary
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
Top reviews
No reviews yet.
You May Also Like
Are you a qualified
Trainer or Instructor?
Join Care Learning as a trainer and deliver high-quality courses to learners across healthcare and workplace training.
Refer a Friend &
Earn Rewards.
Invite healthcare professionals to join Care Learning and get rewarded when your referral successfully joins.
Frequently asked questions
A maintenance regimen combining an inhaled corticosteroid (ICS), long‑acting beta‑agonist (LABA), and long‑acting muscarinic antagonist (LAMA).
When asthma is not controlled with medium‑ or high‑dose ICS/LABA despite good adherence.
Yes, single‑inhaler triple combinations are available and may improve adherence.
Improved lung function and reduced exacerbations in selected patients.
No. It’s a step‑up option after dual therapy is insufficient.
Proper technique ensures optimal drug delivery and therapeutic effect.
.jpg)
.jpg)
.jpg)



